Osiris Therapeutics, Inc. (NASDAQ:OSIR) Stock Quotes and News

Osiris Therapeutics, Inc. (OSIR) 11.42 -0.05

Price Open:	11.17	Day's Range:	6.55090 - 11.75010
Price Close:	11.07	52wk Range:	4.12 - 14.46
Price Day Change:	-0.05	Volume:	51,085
Price % Change:	-0.45	Market Cap:	362.9M
Bid:	9.99000	PE Ratio:	0
Ask:	11.42000	EPS Diluted:	-0.384

Trade OSIR NOW!

The Latest On OSIR

Market Wrap for Wednesday, March 6: Stocks Close Mixed as Euro Tests Key Support Level Ahead of ECB Meeting 3/6/13 5:09pm

UPDATE: Piper Jaffray Upgrades Osiris Therapeutics to Overweight on Strong Biosurgery Growth 3/6/13 12:30pm

Earnings Scheduled For March 6, 2013 3/6/13 5:13am

Osiris Therapeutics Wins Title of European Orphan Drug Status for Prochymal 2/19/13 8:39am

Osiris Therapeutics Concludes Successful Defense of Stem Cell Patent Challenge in Australia 2/18/13 8:45pm

Swissmedic Says Osiris Prochymal Therapeutics Prochymal to be Evaluated Under Rapid Authorization Procedure 9/28/12 7:05am

Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen 9/28/12 6:07am

Osiris Therapeutics Says Board Member Barnhill Passed Away; Elects Klingemann in Place 9/20/12 9:02am

These Are Four of the Hottest Biotechs in the Market Right Now 7/5/12 1:19pm

Prochymal Significantly Reduces Hypertrophy, Arrhythmia and Progression to Heart Failure in Patients Suffering a Heart Attack 7/2/12 8:20am

'Biological Legos' Could Become a Blockbuster Innovation For Osiris Therapeutics 6/20/12 4:14pm

Bullish setups to watch next week 6/15/12 5:59pm

Press Releases

Osiris Therapeutics Announces First Quarter 2013 Financial Results 5/7/13 Business Wire

Osiris Therapeutics to Present at the 12th Annual Needham Healthcare Conference 4/29/13 Business Wire

Osiris Therapeutics Announces First Quarter 2013 Financial Results Conference Call 4/25/13 Business Wire

The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Host 2nd International Vatican Adult Stem Cell Conference 4/11/13 GlobeNewswire

The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference 3/22/13 GlobeNewswire

Osiris Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference 3/14/13 Business Wire

Osiris Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results 3/6/13 Business Wire

Osiris Therapeutics Establishes Direct Sales Force for Grafix® 3/1/13 Business Wire

Osiris Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results Conference Call 2/22/13 Business Wire

Osiris Therapeutics Receives Title of European Orphan Drug Designation for Prochymal® 2/19/13 Business Wire

Osiris Therapeutics Successfully Defends Key Stem Cell Patent Challenge 2/18/13 Business Wire

Get the latest OSIR stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Osiris Therapeutics, Inc. stock price.

Partner Headlines

Pipeline Progress at Gilead - Analyst Blog 5/16/13

Osiris Loss In-Line with Expectations - Analyst Blog 5/8/13

Loss at Aegerion Narrower Than Expected - Analyst Blog 5/3/13

Affymetrix Reports Disappointing 1Q - Analyst Blog 5/2/13

Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog 5/1/13

Double Setback for Gilead - Analyst Blog 4/30/13

Geron Narrows Loss; Cuts Jobs - Analyst Blog 4/29/13

Biogen's Earnings Surpass Expectations - Analyst Blog 4/25/13

Sanofi's Vaccine Gets EU Approval - Analyst Blog 4/22/13

Vertex CF Candidate Impresses - Analyst Blog 4/19/13

Affymetrix Down to Underperform - Analyst Blog 4/15/13